scispace - formally typeset
Open AccessJournal ArticleDOI

Fibroblast growth factors, their receptors and signaling.

Ciaran Powers, +2 more
- 01 Sep 2000 - 
- Vol. 7, Iss: 3, pp 165-197
Reads0
Chats0
TLDR
FGF signaling also appears to play a role in tumor growth and angiogenesis, and autocrine FGF signaling may be particularly important in the progression of steroid hormone-dependent cancers to a hormone-independent state.
Abstract
Fibroblast growth factors (FGFs) are small polypeptide growth factors, all of whom share in common certain structural characteristics, and most of whom bind heparin avidly. Many FGFs contain signal peptides for secretion and are secreted into the extracellular environment, where theycan bind to the heparan-like glycosaminoglycans (HLGAGs) of the extracellular matrix (ECM). From this reservoir, FGFs mayact directlyon target cells, or theycan be released through digestion of the ECM or the activityof a carrier protein, a secreted FGF binding protein. FGFs bind specific receptor tyrosine kinases in the context of HLGAGs and this binding induces receptor dimerization and activation, ultimatelyresulting in the activation of various signal transduction cascades. Some FGFs are potent angiogenic factors and most playimportant roles in embry onic development and wound healing. FGF signaling also appears to playa role in tumor growth and angiogenesis, and autocrine FGF signaling maybe particularlyimportant in the progression of steroid hormone-dependent cancers to a hormone-independent state.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Dovitinib: rationale, preclinical and early clinical data in urothelial carcinoma of the bladder.

TL;DR: In vitro data on the use of neutralizing monoclonal antibodies targeting FGFR3 show that it can be a more efficient strategy to reach the same goal, with the potential advantage of less toxicity.
Journal ArticleDOI

Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide Drugs.

TL;DR: On 1 April 2016, the Food and Drug Administration approved Defitelio, known for many years as Defibrotide (DF), for marketing in the United States, which is severe hepatic veno-occlusive disease following high-dose chemotherapy and autologous bone marrow transplantation, a toxicity of therapy with a high mortality.
Journal ArticleDOI

Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province.

TL;DR: Associations of variants in FGFR3 and FGFR4 with breast cancer in women from Heilongjiang Province showed that SNP rs351855 was associated with lymph-node-positive breast cancer with a dose-dependent effect of the minor allele, while no significant associations were detected between other SNPs and breast cancer.
Book ChapterDOI

The Fibroblast Growth Factor (FGF) Signaling Complex

TL;DR: The role of the F GF family in specific biological systems, the diverse signaling pathways impacted by the FGF signaling system, and the irreconcilable differences in structural models of theFGF signaling complex are explained in this chapter.
Journal ArticleDOI

Transcriptome Analysis Showed a Differential Signature between Invasive and Non-invasive Corticotrophinomas.

TL;DR: A differential pattern of genetic signature in a subgroup of MAC is revealed, supporting a genetic influence on corticotrophinomas in patients with CD and identifying potential biological pathways associated with growth and invasiveness.
References
More filters
Journal ArticleDOI

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

TL;DR: It is demonstrated that free heparin and heparan sulfate can reconstitute a low affinity receptor that is, in turn, required for the high affinity binding of bFGF.
Journal ArticleDOI

Protein modules and signalling networks

TL;DR: This work highlights conserved protein domains that act as key regulatory participants in many of these different signalling pathways in multicellular organisms.
Journal ArticleDOI

Thalidomide is an inhibitor of angiogenesis.

TL;DR: Electron microscopic examination of the corneal neovascularization of thalidomide-treated rabbits revealed specific ultrastructural changes similar to those seen in the deformed limb bud vasculature of Thalidomid-treated embryos.
Journal ArticleDOI

Receptor specificity of the fibroblast growth factor family.

TL;DR: It is demonstrated that FGF 1 is the only FGF that can activate all FGF receptor splice variants and the relative activity of all the other members of the FGF family is determined.
Related Papers (5)